Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 12, 2009

29777_dirs_2009-02-11_aecdabfb-682b-4c13-9661-0bde2f4bd8ae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-09

Reporting Person: LINDER GREG W (Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-09 Common shares without par value M 8143 $56.30 Acquired 158580 Direct
2009-02-09 Common shares without par value M 1758 $56.85 Acquired 160338 Direct
2009-02-09 Common shares without par value S 8143 $56.99 Disposed 152195 Direct
2009-02-09 Common shares without par value S 1758 $57.00 Disposed 150437 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-09 Option (right to buy) $56.30 M 8143 Disposed 2009-02-11 Common Shares (8143) Direct
2009-02-09 Option (right to buy) $56.85 M 1758 Disposed 2009-02-11 Common Shares (1758) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 12787 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 9, 2009.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.